Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayMay 07, 2021 3:08 pm

NetworkNewsBreaks – Healthy Extracts Inc. (HYEX) Leads Research and Manufacture of Beneficial Plant-Based Formulations

Healthy Extracts (OTCQB: HYEX) has continued to strengthen its stronghold in the health and lifestyle industry by researching and manufacturing plant-based formulations offering supplements that are beneficial for heart and nerve health. HYEX has broadened its portfolio through acquisitions of unique assets, BergaMet North America and Ultimate Brain Nutrients (“UBN”). “Healthy Extracts Inc. recently announced positive results of clinical studies for two leading products: BergaMet North America’s HERHEART(TM) and Ultimate Brain Nutrients’ Fuel4Thought(TM) Brain Booster,” reads a recent article. “Duke Pitts, CEO of BergaMet North America, stated that HERHEART(TM) is a natural supplement that is scientifically formulated specifically for women…

Continue Reading

FridayMay 07, 2021 2:52 pm

NetworkNewsBreaks – ISW Holdings Inc.’s (ISWH) TeleCare Subsidiary Offers High-Level Independence, Supportive Care

ISW Holdings (OTC: ISWH), a global brand management holdings company with commercial operations in telehealth and cryptocurrency mining, recently launched TeleCare Home Health LLC, its wholly owned subsidiary. With this launch, ISWH has positioned itself to capitalize on the growth in the telehealth/home health care market, projected to grow to $515.6 billion by 2027, up from $300 billion in 2020. The subsidiary has developed a new TeleCare Home Health solution, which “provides a simple, one-button wearable device for the patient that summons help much like the nurse call button at the hospital,” explains a recent article. “This small telehealth solution…

Continue Reading

FridayMay 07, 2021 2:36 pm

NetworkNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) Poised for Opportunity Amid Rising Demand

Uranium Energy (NYSE American: UEC) is positioned to benefit from the increased demand for low-cost and environmentally friendly uranium. This comes as the U.S. Democratic Party has changed its stand on nuclear energy for the first time since the Nixon administration in 1972. The move by the new administration bodes well for Uranium Energy. A recent article reads, “UEC has used and will be using in-situ recovery (‘ISR’) technology at its fully licensed projects. The company’s resource base of fully permitted ISR projects is the largest of any U.S.-based producer. These projects and the green technology they utilize have situated…

Continue Reading

FridayMay 07, 2021 1:40 pm

NetworkNewsBreaks – DGTL Holdings Inc. (TSX.V: DGTL) (OTCQB: DGTHF) Strong Presence as Savvy Companies Seek Martech Options

DGTL Holdings (TSX.V: DGTL) (OTCQB: DGTHF) is the focus of a recent NetworkNewsAudio news podcast. The podcast talked about the impact COVID-19 has had on martech and digital advertising. The piece points out that in today’s world, savvy brands realize that they must transition to digital outreach or fail. The podcast cites a recent survey that reported more than 49% respondents said they shop more online now than pre-COVID, including 62% of Americans, 59% in Canada and 70% in Mexico. Another study indicated that 70% of businesses surveyed said that marketing had become more important during the pandemic for reasons spanning…

Continue Reading

FridayMay 07, 2021 1:36 pm

NetworkNewsBreaks – Imagin Medical Inc.’s (CSE: IME) (OTCQB: IMEXF) i/Blue(TM) Imaging System to Enable More Accurate Tumor Resection

Imagin Medical (CSE: IME) (OTCQB: IMEXF), a surgical imaging company, has made notable strides in its quest to offer innovative technology for visualizing cancer. Designed to address the limitations of both white and blue light cystoscopy procedures, IME’s i/Blue(TM) Imaging System displays real-time white and blue light images on the screen simultaneously. This eliminates the need for the surgeon to switch back and forth between images, as is the case with blue light cystoscopy. On the other hand, it addresses the limitation of the white light cystoscopy, which is notorious for not clearly defining the margins between flat tumor and…

Continue Reading

FridayMay 07, 2021 1:28 pm

NetworkNewsBreaks – Infobird Co. Ltd. (NASDAQ: IFBD) Featured in Exclusive Broadcast

Infobird (NASDAQ: IFBD)  today announced the availability of a broadcast titled, “China Is Next Frontier in SaaS Revolution.” The piece discusses Infobird’s positioning as one of the few software-as-a-service (“SaaS”) companies in China with the capability to transition into a standard SaaS business model and serve both mid-to-large enterprises and SMEs by leveraging its no-code development platform. According to the audio press release, “A leading SaaS provider of patented, innovative AI-powered, customer-engagement solutions in China, the company earned its stripes by creating and delivering customized SaaS solutions for some of the largest commercial banks in the nation. Coming off a…

Continue Reading

FridayMay 07, 2021 1:04 pm

NetworkNewsBreaks – Amesite Inc. (NASDAQ: AMST) Founder, CEO Featured Guest on RedChip Money Report Interview

Amesite (NASDAQ: AMST), an artificial intelligence software company providing offering a cloud-based platform and content creation services for business, university and K-12 learning and upskilling, has announced that founder and CEO Dr. Ann Marie Sastry will be the featured guest speaker on a recent interview to be broadcast on “The RedChip Money Report(R),” which offers commentary on small-cap investing as well as interview with executives of public companies. The  interview is scheduled for broadcast on Bloomberg TV on Saturday, May 8, 2021, at 7 p.m. local times; the broadcast will reach 73 million homes in the United States. In addition, the interview is available…

Continue Reading

FridayMay 07, 2021 12:57 pm

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Conference/Webcast to Discuss Q1 Results, Provide Clinical Pipeline Update

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, today announced that it will host a conference call and live webcast to discuss its first quarter 2021 results and provide an update on its clinical pipeline. The event is scheduled to take place at 5:30 p.m. ET on Thursday, May 13, 2021. Interested parties may visit https://nnw.fm/rMRlW to register, as well as join the call by dialing 888-506-0062 (Toll-Free) or 973-528-0016 (International) and entering code: 396394. Participants are asked to dial in approximately five…

Continue Reading

FridayMay 07, 2021 12:09 pm

NetworkNewsBreaks – Karuna Therapeutics, Inc. (NASDAQ: KRTX) Featured in Mizuho Securities Research Report

Karuna Therapeutics (NASDAQ: KRTX) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Karuna released 1Q21 earnings today, but quarterly financial performance is less important for a clinical-stage company such as Karuna. More important are updates on the progress of flagship drug KarXT, and we are encouraged by the progress there. The two pivotal Phase 3 trials (EMERGENT-2 and EMERGENT-3) and 52-week EMERGENT-4 trial are enrolling, while EMERGENT-5 will be initiated in 2Q21. The Phase 1b safety and tolerability trial in healthy elderly volunteers also continues, with Cohort 3 data expected later…

Continue Reading

FridayMay 07, 2021 12:08 pm

NetworkNewsBreaks – Nkarta, Inc. (NASDAQ: NKTX) Featured in Mizuho Securities Research Report

Nkarta (NASDAQ: NKTX) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Nkarta and CRISPR Therapeutics (CRSP, not covered) announced a 50/50 collaboration to develop two NK cell therapies. One of these will target CD70 for indications including solid tumors and one is still TBD. They will also develop a combination NK+T cell therapy to target both innate and adaptive immunity. Additionally, Nkarta receives a license to use CRISPR technology to edit five gene targets in any of its own assets.”To request access to the full report, visit http://nnw.fm/SaZ9d About Nkarta, Inc.Nkarta is…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000